Lupus anticoagulant
Overt increase in lupus anticoagulant level in HIV patients co-infected with pulmonary Mycobacterium tuberculosis infection: A prospective cohort study
6
Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2 glycoprotein I
6
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant
11
Acquired factor VIII inhibitor and lupus anticoagulant presenting with prolonged aPTT: a case report
6
Anti beta2 glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant like activity enhance the beta2GPI binding to phospholipids
10
Localization of the apoptosis inducing activity of lupus anticoagulant in an annexin V binding antibody subset
10
Original Article Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death
6
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant
13
Thrombin generation as marker to estimate thrombosis risk in patients with abnormal test results in lupus anticoagulant routine diagnostics
7
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity Mechanism of a lupus anticoagulant
10
Further investigations of lupus anticoagulant interference in a functional assay for tissue factor pathway inhibitor
5
Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant
7
Profile of patients with Thrombosis evaluated in a Tertiary Care Center.
91
LA and aCL in an unselected popula- tion of children with idiopathic cerebral ischemia and to compare the clinical and radiological features observed in aPL-positive and aPL-negative patients. PATIENTS AND METHODS
6
Anticardiolipin antibodies in unexplained pregnancy loss
107
Role of Antiphospholipid Antibody in Early Pregnancy Loss
5
Acquired activated protein C resistance and thrombosis in multiple myeloma patients
6
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay
9
Assessment of Antiphospholipid Antibodies, CD4 Count and Some Haematological Parameters in HIV Patients attending a Tertiary Health Institution in South-Western Nigeria
14
On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies
9